Promimic AB (ST:PRO) — Market Cap & Net Worth
Market Cap & Net Worth: Promimic AB (PRO)
Promimic AB (ST:PRO) has a market capitalization of $22.97 Million (Skr213.48 Million) as of May 4, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #24597 globally and #490 in its home market, demonstrating a 6.60% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Promimic AB's stock price Skr11.30 by its total outstanding shares 18892326 (18.89 Million). Analyse Promimic AB operating cash flow efficiency to see how efficiently the company converts income to cash.
Promimic AB Market Cap History: 2022 to 2026
Promimic AB's market capitalization history from 2022 to 2026. Data shows change from $23.58 Million to $22.97 Million (-8.72% CAGR).
Promimic AB Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Promimic AB's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.78x
Promimic AB's market cap is 0.78 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $23.58 Million | $16.21 Million | -$15.89 Million | 1.45x | N/A |
| 2023 | $66.48 Million | $37.07 Million | -$9.22 Million | 1.79x | N/A |
| 2024 | $45.75 Million | $43.98 Million | -$12.55 Million | 1.04x | N/A |
| 2025 | $34.46 Million | $44.40 Million | -$8.80 Million | 0.78x | N/A |
Competitor Companies of PRO by Market Capitalization
Companies near Promimic AB in the global market cap rankings as of May 4, 2026.
Key companies related to Promimic AB by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #141 globally with a market cap of $155.56 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #208 globally with a market cap of $112.79 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #230 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #236 globally with a market cap of $102.56 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #141 | Abbott Laboratories | NYSE:ABT | $155.56 Billion | $89.46 |
| #208 | Stryker Corporation | NYSE:SYK | $112.79 Billion | $294.73 |
| #230 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #236 | Medtronic PLC | NYSE:MDT | $102.56 Billion | $80.00 |
Promimic AB Historical Marketcap From 2022 to 2026
Between 2022 and today, Promimic AB's market cap moved from $23.58 Million to $ 22.97 Million, with a yearly change of -8.72%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr22.97 Million | -33.33% |
| 2025 | Skr34.46 Million | -24.67% |
| 2024 | Skr45.75 Million | -31.19% |
| 2023 | Skr66.48 Million | +181.90% |
| 2022 | Skr23.58 Million | -- |
End of Day Market Cap According to Different Sources
On May 3rd, 2026 the market cap of Promimic AB was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $22.97 Million USD |
| MoneyControl | $22.97 Million USD |
| MarketWatch | $22.97 Million USD |
| marketcap.company | $22.97 Million USD |
| Reuters | $22.97 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Promimic AB
Promimic AB (publ) manufactures, markets, and sells biomaterials for improved osseointegration for orthopedic and dental implants markets. It offers HAnano surface technology that combines various properties that are known to improve osseointegration into one unique surface modification. The company was incorporated in 2004 and is based in Mölndal, Sweden.